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CaF
2 
(Mn) suspended in organic liquids. Spurny and his colleagues
(20) 
studied the 
effects on TL response of suspending LiF in water. The mechanism of the changes in 
response of TL materials in these liquids is not completely clear. The effects on 
TL response of suspending a TLD powder in an organic matrix (such as PAC) to mold 
"dosimetric organs" has not been investigated. 
Proposed Research-Summary of Progress  
During the past year the dosimetry research program has continued in the 
School of Nuclear Engineering and Health Physics at the Georgia Institute of 
Technology. The major objective of this program has been to provide research 
results upon which a useful internal dosimetry system could be based. The impor-
tant application of this dosimetry system will be the experimental verification of 
internal dosimetry calculations such as those published by the MIRD Committee 
(1,2). 
Specific research goals attained will be divided into several categories in 
order to discuss the progress in each area. 
A. 	Preparation of Organ Models  
One of the first challenges encountered during the last period was devis-
ing methods to produce a dosimetric organ for use in the experiments which 
matched as closely as possible the organs of the mathematical phantom. Ini-
tially, solid replicas of three organs were obtained from the Oak Ridge 
National Laboratory (ORNL). These replicas, which were fashioned from bake-
lite and coated with silicone, were used to produce organs for use in the 
original MR. ADAM. 
Several techniques were investigated which could produce the organ molds 
for use in the experiment. The first technique studied was the use of 
labstone* and plaster of paris to produce a rigid mold into which the PAC 
*Labstone is a material similar to plaster of paris which is used by the 
dental profession to prepare positive models of the teeth. 
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mixture could be poured and solidified. Procedures were formulated which were 
satisfactory for producing molds of small organs, e.g., kidneys. A detailed 
procedure for preparation of molds by this technique is given in Appendix I. 
Molds produced by the above procedure were found to be too fragile for 
repeated use. Molds often chipped or completely shattered during routine use 
due to the stresses generated by the necessary clamping devices. A second 
technique for preparing molds was developed and the resulting molds will be 
used to produce the dosimetric organs for use in this study. This technique 
is described below. 
Organs for use in the radiation dosimetry measurements were fabricated 
using the following procedures. A computer routine
(21) 
was used to plot-out 
cross-sections of the phantom at 1 cm intervals along the vertical axis of the 
phantom. Organs, for which organ molds were required, were identified and the 
shapes were traced from the computer plots onto hardwood boards (1 cm thick). 
The shapes were cut out, assembled, and fabricated to create positive wooden 
replicas of the mathematical organs (see Figure 1). A second set of identical 
positive replicas was produced and sent to the University of Chicago for use 
in their studies. In this manner direct comparisons of the two experimental 
dosimetry techniques may be possible in the future. 
The dosimetry technique suggested by Feher et 
a1.(13) 
required a nega-
tive mold to produce a dosimeter which matches the organ shape. As mentioned 
above, several techniques were considered including plaster of paris - stone 
casting, vacuum plastic molding, and plaster bandage molding. The latter 
technique was selected because it was inexpensive, was relatively rapid, and 
the mold properties were superior to those obtained by other methods. 
The procedure for forming negative organ molds is as follows. A hardwood 
mold was pre-treated with a thin film of silicone lubricant to provide swift 
-7- 
removal of the plaster mold. 	Several layers of the quicksetting plaster 
bandages* were mixed with water and wrapped around the pretreated mold. Band-
ages were applied to the mold until a layer approximately 2 cm thick was 
formed. The plaster "cast" was allowed to harden, at room temperature for a 
short time until it was sufficiently rigid to be cut. Then the cast was cut 
into two pieces for future removal of the organ mold. However, the mold was 
allowed to set-up completely for more than 18 hours, at room temperature, with 
the positive mold still inside to avoid shrinkage and assure structural integ-
rity. 
After removal of the positive organ mold the two halves of the plaster 
(negative) mold are rejoined and held together with additional strips of the 
plaster bandages (see Figure 1). These negative molds, produced by the above 
procedures, will be used to form the required volumetric dosimeters. The 
dosimeter itself will be formed from combinations of tissue equivalent mate-
rials and thermoluminescent powders. The intial material is a liquid which is 
introduced into the negative mold and is solidified rapidly (see Figure 1). 
This procedure will be discussed in a subsequent section of this progress 
report. 
B. 	Preparation of Organ Dosimeters  
Initially organ dosimeters were to be fabricated using a combination of 
paraffin, alkyl-chloride, and thermoluminescent powder (LiF). Samples of 
several diferent n-alkyl-chlorides were obtained from a commercial vendor. 
Organs molded from this material were extremely soft at room temperature and 
were extremely difficult to handle without deforming the organ shape. In 
*Johnson and Johnson Products, Inc., New Brunswick, NY 08903 
Figure 1. Photograph of wooden organ (left), plaster of paris mold (center), 
and PATE organ dosimeter for the kidney. 
addition, if left at room temperature, the alkyl chloride "weeped" from the 
organ volume. No effort was made to quantify the loss of material from the 
organ dosimeters but it was a cause for concern and the alkyl-chloride was 
studied further. 
Large samples of the alkyl chloride material were chemically refined to 
remove impurities in an attempt to produce a material which would not "weep" 
when used in the PAC material. These experiments indicated that the alkyl-
chloride samples contained large quantities of confined water. In addition, 
it was revealed that samples contained an unacceptable amount of foriegn 
material. These studies indicated that the available alkyl-chloride com-
pounds would not be acceptable for use in this research project unless exten-
sive purification procedures were developed. 
Studies of the PAC-paste material using the computer code TECALC (22)  
indicated that the photon interaction cross-sections did not match those of 
the tissue it was intended to represent. In addition, the density of the PAC-
paste was determined to be 0.87 gm/cm
3 
rather than the essentially 1 gm/cm
3 
required to match tissue. 
For the above reasons, it was decided to delay fabrication of organ 
dosimeters using the PAC mixture and to initiate a search for other acceptable 
substitute materials. Several substances were identified as possible substi-
tutes but only one of these was currently available at a cost which allowed 
extensive use in the proposed research. This material was tetrachlorobenzene 
(C 6H2C14 ). 
The organ dosimeter prepared by mixing paraffin, tetrachlorobenzene, and 
thermoluminescent powder was called the PATE dosimeter. This dosimeter was 
composed of 2% TLD-100, 11.2% 
C6HC14' 
and 86.8% paraffin. Table 1 presents a 
summary of the general characteristics of the organ dosimeter. 
TABLE 1. General Characteristics of the PATE Organ Dosimeter 
Composition by weight 
TLD-100 	  
Tetrachlorobenzene 	 




Effective Atomic Number: 7.35 
Number of Electrons Per Gram: 3.41 x 10
23 
Average Atomic Weight: 11.87 
Net Chemical Composition 
Hydrogen 	  13.8% 
Carbon 	  78.6% 
Lithium 	  0.5% 
Fluorine 	  .. 1.5% 
Chlorine 	  0. 5.7% 
The PATE dosimeter is prepared according to the following procedure: 
a. screen the TLD-100 powder through the 100 and 200 Tyler mesh screens 
to ensure uniformity of the powder. 
b. grind the tetrachlorobenzene into a fine powder and pass it through 
the 200 Tyler mesh screen. 
c. weigh out the proper amounts of the constituents of the PATE organ 
dosimeter. 
d. combine the paraffin and tetrachlorobenzene and melt at a tempera- 
ture of 75-80°C while stirring the mixture. 
e. when melting is complete, pour the mixture through the 200 Tyler 
mesh screen and collect the resultant liquid. 
f, 	add the weighed amount of TLD-100 powder to the mixture and agitate 
to insure uniform mixing. 
g. allow the mixture to cool, while stirring, to about 50 °C, then pour 
the mixture into the mold. 
h. allow the mixture to cool and solidify completely before removing 
from the mold. 
The mold itself is prepared for use by lining the inside of the mold with 
aluminum foil. The foil facilitates removal of the organ dosimeter from the 
mold. Other coating materials, such as silicone, were transferred from the 
mold to the PATE material upon cooling. The contamination of the organ 
dosimeter by this material led to the use of aluminum foil to line the inside 
of the molds. To expedite rapid cooling of the PATE mixture the mold is 
cooled in a deep freezer and, in some cases, the pouring is carried out in the 
freezer. In some cases additional PATE must be added to the mold because of 
shrinkage due to cooling. 
The above procedure produces an organ dosimeter with qualities much 
superior to those obtained with the PAC mixture. The organ has a pure white 
color and the consistency of the material is much harder than the previous 
material. Tetrachlorobenzene has a higher melting point and there is no 
evidence of weeping or other mechanisms which may lead to a loss of material. 
Photon attenuation cross-sections determined with TECALC (27) and the density 
of the PATE material match those of tissue more closely. 
C. 	Recovery of TLD from the PATE Organ Dosimeter  
Techniques for the recovery of the thermoluminescent powder from the 
organ dosimeter were studied extensively during the past year. These studies 
were the result of a change from alkyl-chloride to tetrachlorobenzene as a 
major constituent of the dosimeter. The current procedure used for recovery 
is as follows: 
a. place the organ dosimeter in a large beaker and add carbon tetra-
chloride (CC1
4
) in a 1:2 ratio by volume. 
b. heat the mixture while keeping the temperature at or below 80 °C. 
c. once the PATE mixture has dissolved, pour the entire mixture 
through the 200 Tyler mesh screen and wash the beaker with extra 
CC1
4 
until all TLD-100 crystals are removed. 
d. wash the screen with more CC1
4 
until the TLD crystals appear to be 
completely free of paraffin. 
e. allow the TLD crystals to air-dry while on the screen. 
f. once the crystals are dry, pass the recovered crystals through the 
100 and 200 Tyler mesh screens to remove any collected impurities. 
g. before evaluating the TLD crystals, preanneal the crystals at 100 °C 
for 10 minutes. 
h. 	read the TLD crystals on a thermoluminescent dosimeter reader 
following manufacturer's recommended procedures for heating rate, 
maximum temperature, etc. 
Recovery of TLD crystals by the above procedure has been quite good with an 
average recovery rate of about 96%. 
D. 	Distribution of the TLD in the PATE Organ Dosimeter  
A study was initiated to determine the ability of the molding technique 
(described in B. above) to produce an organ dosimeter which had a uniform 
distribution of the TLD powder. A cylindrical plaster-bandage mold was fabri-
cated for use in this study. The inside of the cylinder had a diameter of 5.3 
cm and a height of 30 cm. 
A 500 g sample of the PATE mixture was prepared following the procedures 
described above. The PATE mixture contained 10.0 g of TLD-100, 55.85 g of 
tetrachlorobenzene, and 434.15 g of paraffin. The mold was kept in the 
freezer until the PATE mixture was ready for pouring. After filling the mold 
with liquid PATE, the mold was replaced in the freezer in a vertical position. 
After cooling, the solidified PATE cylinder was removed from the 
plaster-bandage mold and cut into 13 slices. The thickness and mass of each 
slice was determined before attempting to recover the TLD-100 powder. The 
data obtained in this study are summarized in Table 2. Note that the PATE 
mixture prepared for this experiment was not sufficient to fill the mold 
completely. This fact is reflected in column 3 of the table. Slice number 
one corresponds to the bottom of the cylinder whereas slice number thirteen is 
the upper portion of the cylinder. Note the extremely uneven distribution of 
the TLD-100 powder in the mold. In addition, note that the TLD recovery in 
this experiment was only approximately 81%. Further investigation of the 
glassware used in the experiment revealed that 1.41885 g of material had 
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remained in the beaker and the funnel. Subsequent refinement of the recovery 
procedure (discussed previously) indicates that the recovery may ultimately 
approach 100%. 
The data presented here are representative of several of the distribu-
tion studies performed to date. The skewed distribution indicates that other 
procedures must be developed in order to ensure a uniform distribution of the 
TLD powder in the organ dosimeter. At the present time, organ molding tech-
niques are being investigated which utilize a layering process to overcome 
these problems. Preliminary results are given below which indicate that this 
technique should be successful. Inspection of the complete PATE molded organs 
has shown good joining of the layers. In fact, once the mold has solidified 
the individual layers are not identifiable to the naked eye. No boundaries 
are visible and the layered organ dosimeters exhibit similar physical charac-
teristics to those molded at one pouring. 
E. 	Modified Molding Techniques  
As mentioned above, modified molding techniques have been developed to 
overcome the TLD setting problem. In this modified procedure the paraffin and 
tetrchlorobenzene are combined, melted and solidified before the organ mold-
ing procedure is begun. The procedure is as follows: 
a. melt paraffin and C 6H2C1 4 at a temperture of about 80-100 °C. 
b. pour this mixture through the 200 Tyler mesh screen. 
c. allow the mixture to solidify in a shallow stainless steel pan. 
d. when organ dosimeters are to be formed, break the paraffin-tetra-
chlorobenzene material into chunks. 
e. place about 100 g of these chunks in a beaker and remelt at about 
80-100 °C. 














1 2.042 2.042 45.05492 7.51645 16.6829 
2 1.431 3.473 31.57830 0.29480 0.9336 
3 1.552 5.025 39.23465 0.13410 0.3917 
4 1.137 6.162 25.08504 0.03795 0.1513 
5 1.467 7.629 32.37079 0.03720 0.1149 
6 1.082 8.711 23.87346 0.02165 0.0907 
7 1.567 10.278 34.56629 0.02178 0.0360 
8 1.532 11.810 33.79788 0.02650 0.0783 
9 1.972 13.782 43.51380 0.02220 0.0510 
10 1.562 15.644 34.46477 0.01388 0.0402 
11 1.922 17.566 42.41088 0.01012 0.0239 
12 1.455 19.021 32.09712 0.00005 0.0002 
13 1.617 20.638 35.66424 0.01068 0.0299 
Total weight of TLD recovered 8.14735 g 
f. screen the TLD-100 crystals through the 100 and 200 Tyler mesh 
screen. 
g. weigh out proper amount of the TLD-100 cyrstals for use. 
h. pour a portion of the melted mixture into a 50 ml beaker and add the 
correct amount of TLD powder. Stir the mixture well and pour the 
liquid PATE into another beaker for future use. 
i. pour another 50 ml of the melted mixture into the same beaker and 
add the required amount of TLD powder. Pour this liquid PATE into 
the organ mold and allow 10-15 minutes for solidification. 
j 	repeat step i, allowing for solidification, until the mold is com- 
pletely filled. 
The distribution study described in D. above was repeated using the above 
described procedure. The right circular cylinder of PATE was cut into 17 
slices. Each slice was measured, dissolved and the TLD crystals recovered 
according to established procedures. The data from this experiment are shown 
in Table 3. The mean concentration in the 17 slices is 1.086 + 0.470 g of TLD 
powder. However, close inspection of the table indicates a problem with top 
four slices (slices 14-17). The high concentration in slice 14 is thought to 
be due to the lack of aherence to the established procedure. That is, the 
PATE layer was not allowed to solidify completely before subsequent layers 
were poured. The mean concentration in slices 1-13 was found to be 1.120 + 
0.216 g of TLD powder. This variation in the TLD distribution (± 20%) is 
considered acceptable for use in the present study. However, further refine-
ments are being studied at this time which are expected to reduce the present 
variations. 
F. Effect of the PATE Mixture on the TLD Response  
Before the PATE mixture can be used successfully in this dosimetry re-
search the response characteristics of the TLD powder must be investigated. 
Preliminary investigations on the PAC material (reported last year) indicated 
no significant changes in response. However, the subsequent change from alkyl 
chloride to tetrachlorobenzene has necessitated further study of the TLD 
response characteristics. The results of these studies are not available for 
inclusion in this progress report. Nevertheless, preliminary results indi-
cate that any change in response may actually be due to incomplete removal of 
the paraffin from the crystals. The modified recovery procedure (discussed in 
C. above) was designed to insure the recovery of clean crystals. 
G. Investigation of Chemical Dosimetry Systems  
A preliminary literature survey, reported in the last progress report, 
indicated that the ferrous sulphate-benzoic acid-xylenol orange dosimetry 
system (FBX) had ^haracteristics suitable for use in this research. The FBX 
system consists of 0.2 mM ferrous ammonium sulphate, 5.0 mM benzoic acid, and 
0.2 mM xylenol orange in 0.05 N sulphuric acid. The dosimeter could be used 
for dosimetry of X, gamma, and neutron radiation in the dose range of 0.1 - 
3000 rad. The dosimetric solutions could be stored for about 2 weeks before 
irradiation and up to 3 days after irradiation without any significant error 
in dose estimations (22). 
Further investigation of the FBX system indicated that this system was 
not suitable for use in this research. Although the dose range reported in 
the literature was 0.1 - 3000 rads the accuracy at 100 mrad was + 50 mrad. The 
chemical procedures and equipment required to obtain even this level of 
accuracy were also prohibitive. Subsequent publications by the same authors 
TABLE 3. Results of TLD Distribution Study Using 
Modified Molding Techniques 
Cumulative 	Total 
	
Slice 	Height 	Height Weight 	TLD-100 Weight TLD Concentration 
Number (cm) (cm) 	 (g) 	(g) 	 (g)  
1 0.68 0.68 14.95150 0.19273 1.289 
2 0.88 1.56 19.37895 0.24385 1.258 
3 1.42 2.98 31.28255 0.43510 1.390 
4 1.22 4.20 26.83448 0.35420 1.320 
5 1.72 5.92 38.01695 0.34540 0.909 
6 1.23 7.15 27.21747 0.21915 0.805 
7 1.03 8.18 22.68863 0.24100 1.062 
8 1.42 9.60 31.38180 0.38513 1.227 
9 1.78 11.38 39.23075 0.43495 1.109 
10 1.25 12.63 27.58180 0.20190 0.732 
11 1.12 13.75 24.61440 0.24365 0.990 
12 1.31 15.06 28.8653 0.40120 1.390 
13 1.10 16.16 24.25600 0.26130 1.077 
14 1.77 17.93 38.95190 0.93115 2.391 
15 1.37 19.30 30.30130 0.27295 0.901 
16 1.39 20.69 30.6400 0.11150 0.364 
17 2.98 23.67 65.84770 0.16225 0.246 
(23) conculded that use of a spectrophotometer with a 10 cm cell length 
probably had a sensitive limit in the range of 1-4 rads rather than 100 mrad 
reported earlier. This technique was not investigated further due to the 
stated accuracy in the dose range of interest. 
Another system which was investigated used a liquid photographic emul-
sion (24). This dosimeter was designed to be useful in the 0.5 - 6R range. 
The average deviation in response was 2.5% or less for paired samples. The 
concentrations used were approximately tissue equivalent and the variation in 
response from 16 keV to 1.33 MeV was less than 50%. 
Discussions with one of the developers of this system revealed that the 
system, as described in the literature, did not function as well as the 
initial results indicated. Many problems were encountered in the routine use 
of this dosimetry system and the idea was abandoned in favor of suspending TLD 
powder in a silicon liquid media. However, this latter system also was never 
fully developed (25). 
A broad-range chemical dosimetry system described by Klein (26) was also 
investigated. This system used saturated aqueous solutions of benzene and 
could be used to measure accurately doses as low as 10 R. The evaluation at 
this exposure level required the analysis of the radiolysis product phenol in 
the 10
-8 
molar concentration range. This system was not considered further 
due to the capabilities available in our laboratory and the necessity of 
reducing the sensitive exposure range by two orders of magnitude. 
H. 	Calculations of Absorbed Doses by Monte Carlo Techniques  
No final calculations have been performed with which experimental com-
parison can be made. Computer codes to be used in this research have 
previously been installed on the Georgia Tech computer. These codes have been 
debugged and computer results have been compared to test cases supplied with 
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the code. This phase of the research can be completed within one or two weeks 
once the exact tissue-equivalent compositions to be used in the experiments 
have been established. A significant effort has been expended to understand 
the Monte Carlo code and the methods to be used to modify the code before 
producing the final computer data. This effort is intended to allow recalcu-
lation of internal exposure situations which match as closely as possible the 
experimental situation. 
The computer code TECALC
(27) 
has been used extensively to design 
tissue-, bone-, and lung-equivalent materials for use in the MR. ADAM phantom 
as well as the selection of materials to replace the PAC-TLD paste. 
Research Goals for the Renewal Period  
Current progress in this research, coupled with the remaining four months of 
the project, indicate that the research goals will be attained as scheduled. 
However, there are several areas which remain unresolved and for which a renewal of 
this research effort is requested. These areas are discussed below. 
A. 	Consideration of Additional Organs  
Organ molds have been fabricated only for a small number of organs which 
were selected at the inception of this research. It is proposed that the 
initial dosimetry investigation be extended to include many additional or 
gans. Further, it is proposed that complex organs and organ systems be 
studied for inclusion in the research. 
It is proposed that studies be undertaken to investigate the fabrication 
of organ dosimeters for organs which comprise the more complex organ systems 
in the body. For example, the lungs have a density of 0.3 g/cm
3 
whereas the 
present organ dosimeters are designed to simulate tissues with density of 1.0 
g/cm3 In previous studies the lungs have been simulated effectively in order 
to produce the proper scattering and transport medium. However, no attempts 
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